- Home
- VRCA vs EEA Comparison
VRCA vs EEA Comparison
Compare VRCA & EEA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VRCA
- EEA
- Stock Information
- Founded
- VRCA 2013
- EEA 1986
- Country
- VRCA United States
- EEA Germany
- Employees
- VRCA 71
- EEA N/A
- Industry
- VRCA Biotechnology: Pharmaceutical Preparations
- EEA Trusts Except Educational Religious and Charitable
- Sector
- VRCA Health Care
- EEA Finance
- Exchange
- VRCA Nasdaq
- EEA Nasdaq
- Market Cap
- VRCA 43.0M
- EEA 57.7M
- IPO Year
- VRCA 2018
- EEA N/A
- Fundamental
- Price
- VRCA $0.49
- EEA $9.35
- Analyst Decision
- VRCA Hold
- EEA
- Analyst Count
- VRCA 5
- EEA 0
- Target Price
- VRCA $6.00
- EEA N/A
- AVG Volume (30 Days)
- VRCA 431.6K
- EEA 9.2K
- Earning Date
- VRCA 05-12-2025
- EEA 01-01-0001
- Dividend Yield
- VRCA N/A
- EEA 1.92%
- EPS Growth
- VRCA N/A
- EEA N/A
- EPS
- VRCA N/A
- EEA N/A
- Revenue
- VRCA $7,566,000.00
- EEA N/A
- Revenue This Year
- VRCA $127.58
- EEA N/A
- Revenue Next Year
- VRCA $88.06
- EEA N/A
- P/E Ratio
- VRCA N/A
- EEA N/A
- Revenue Growth
- VRCA 47.66
- EEA N/A
- 52 Week Low
- VRCA $0.38
- EEA $7.45
- 52 Week High
- VRCA $11.41
- EEA $9.26
- Technical
- Relative Strength Index (RSI)
- VRCA 47.66
- EEA 62.03
- Support Level
- VRCA $0.45
- EEA $8.76
- Resistance Level
- VRCA $0.59
- EEA $9.36
- Average True Range (ATR)
- VRCA 0.08
- EEA 0.22
- MACD
- VRCA 0.00
- EEA 0.08
- Stochastic Oscillator
- VRCA 26.74
- EEA 98.41
About VRCA Verrica Pharmaceuticals Inc.
Verrica Pharmaceuticals Inc is a dermatology therapeutics company engaged in the development and commercialization of novel treatments that provide a meaningful benefit for people living with skin diseases. Its product candidate, VP-102, is developed for the treatment of molluscum contagiosum, or molluscum, a contagious and pediatric viral skin disease, and common warts.
About EEA The European Equity Fund Inc.
European Equity Fund, Inc / MD is a United States-based diversified, closed-end management investment company. The fund seeks long-term capital appreciation through investment in equity and equity securities of issuers domiciled in Europe. Its portfolio of investments consists of different sectors such as industrials, financials, healthcare, consumer discretionary, materials, consumer staples, information technology, and other sectors.